Announcing a new article publication for Cardiovascular Innovations and Applications journal. Obesity, given its strong association with cardiovascular diseases (CVDs), is a major global public health issue attracting increasing attention.
This comprehensive review systematically synthesizes clinical and basic research progress in elucidating the complex relationship between obesity and CVDs. The authors explore the epidemiology, pathophysiology, clinical manifestations, and management strategies for obesity-related CVDs. Drawing on recent studies, the effects of obesity on atherosclerotic disease, cardiomyopathy, heart failure, arrhythmias, hypertension, and venous thromboembolism are highlighted. Understanding these mechanisms is essential for developing effective prevention and treatment strategies to decrease the cardiovascular burden associated with obesity.
Furthermore, this review summarizes current therapeutic approaches for obesity-related CVDs, such as lifestyle interventions, pharmacotherapy, and metabolic surgery, and discusses future research directions, including precision medicine, exploration of novel therapeutic targets, and single-cell spatiotemporal omics.
Source:
Journal reference:
Naiqi Liu, Yilin Pan and Fukang Liu et al. Obesity and Cardiovascular Diseases: CVIA State-of-the-Art Review. CVIA. 2026. Vol. 11(1). DOI: 10.15212/CVIA.2026.0010. https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2026.0010
GLP-1 drugs may reshape obesity care, but clinicians still have questions